is oral glp 1 effective FDA Approves Semaglutide as the First Oral GLP-1 Pill NEW: This new oral GLP-1
Description
Cummings DM, Lutes LD, Littlewood K, Solar C, Carraway M, Kirian K, et al
Consequently, choosing anti-hyperglycemic therapies with proven cardiovascular and renal benefits is now a cornerstone of T2DM management [2]

Additionally, GLP-1 RAs with established CV benefitsspecifically liraglutide, subcutaneous semaglutide, dulaglutide, and efpeglenatideare recommended for patients with T2DM and ASCVD to reduce CV events, regardless of baseline or target HbA1c levels or concurrent glucose-lowering therapy (Class I, LoE A)

In conclusion, underexplored peptidereceptor systems constitute a vast and largely untapped reservoir of therapeutic potential

Future studies will need to address these issues and improve GLP-1 therapies for older adults

Bolinder J, Ljunggren O, Johansson L, Wilding J, Langkilde AM, Sjostrom CD, Sugg J, Parikh S